Steven R. Feldman, M.D., Ph.D.
Center for Integrative Medicine
Social Sciences & Health Policy
drugs/therapeutic agents pharm, education/training (all f, t,, epidemiology, health services, research/outc, hypertension, immunology/allergy/inflammatio, medical technology/devices
Academic: 336-716-7740 | Department: 336-716-3926
Media Medical Expert »
Sandoval LF, Pierce A, Davis SA, Feldman SR. Improved psoriasis with weight loss: the role of behavioural factors [letter]. Br J Dermatol. 2015;172(3):826-827.
DeFilippis EM, Feldman SR, Huang WW. The genetics of pyoderma gangrenosum and implications for treatment: a systematic review. Br J Dermatol. 2015;172(6):1487-1497.
Taheri A, Mansoori P, Huang KE, Feldman SR. Effect of frequency on entrance and propagation pattern of high-frequency (radiofrequency) electrical currents in biologic tissues. Skin Res Technol. 2015;21(3):291-294.
Taheri A, Moradi Tuchayi S, Alinia H, Orscheln CS, Mansoori P, Feldman SR. Topical clobetasol in conjunction with topical tretinoin is effective in preventing scar formation after superficial partial-thickness burn ulcers of the skin: a retrospective study. J Dermatolog Treat. 2015;26(4):361-364.
Aslam I, Fleischer A, Feldman S. Emerging drugs for the treatment of acne. Expert Opin Emerg Drugs. 2015;20(1):91-101.
Vaidya T, Feldman SR, Kirk J. Patient-centered approach to biologics in the treatment of psoriasis. J Nat Sci. 2015;1(3):e53.
Kuo S, Huang KE, Davis SA, Feldman SR. The rosacea patient journey: a novel approach to conceptualizing patient experiences. Cutis. 2015;95(1):37-43.
Reeder VJ, Gustafson CJ, Mireku K, Davis SA, Feldman SR, Pearce DJ. Trends in mohs surgery from 1995 to 2010: an analysis of nationally representative data. Dermatol Surg. 2015;41(3):397-403.
Anderson KL, Dothard EH, Huang KE, Feldman SR. Frequency of primary nonadherence to acne treatment. JAMA Dermatol. 2015;151(6):623-626.
Anderson KL, Feldman SR. A guide to prescribing home phototherapy for patients with psoriasis: the appropriate patient, the type of unit, the treatment regimen, and the potential obstacles. J Am Acad Dermatol. 2015;72(5):868-878.e1.
Anderson KL, Feldman SR. Reasons for treatment changes in patients with moderate to severe psoriasis. J Cutan Med Surg. 2015;19(4):361-366.
Davis SA, Huang KE, Feldman SR, Fleischer AB Jr, Huang WW. Trends in ambulatory health care usage for adult acne. J Cutan Med Surg. 2015;19(4):377-379.
Gerard AJ, Feldman SR, Strowd L. Quality of life of patients with pyoderma gangrenosum and hidradenitis suppurativa. J Cutan Med Surg. 2015;19(4):391-396.
Hopkinson D, Moradi Tuchayi S, Alinia H, Feldman SR. Assessment of rosacea severity: a review of evaluation methods used in clinical trials. J Am Acad Dermatol. 2015;73(1):138-143.e4.
Moustafa F, Hopkinson D, Huang KE, Feldman S. Prevalence of rosacea in community settings. J Cutan Med Surg. 2015;19(2):149-152.
Radack KP, Farhangian ME, Anderson KL, Feldman SR. A review of the use of tanning beds as a dermatological treatment. Dermatol Ther. 2015;5():37-51.
Farhangian ME, Huang WW, Feldman SR. Adherence to oral and topical medications in cutaneous lupus erythematosus is not well characterized. Dermatol Ther. 2015;5(2):91-105.
Hoffman MB, Farhangian M, Feldman SR. Psoriasis during pregnancy: characteristics and important management recommendations. Expert Rev Clin Immunol. 2015;11(6):709-720.
Langley RG, Feldman SR, Nyirady J, van de Kerkhof P, Papavassilis C. The 5-point Investigator's Global Assessment (IGA) scale: a modified tool for evaluating plaque psoriasis severity in clinical trials. J Dermatolog Treat. 2015;26(1):23-31.
Lin HC, Hunnicutt JN, Moustafa FA, Rohr AL, Huang KE, Balkrishnan R, Feldman SR. Pharmacological treatments in pregnant women with psoriasis in the U.S.A. [letter]. Br J Dermatol. 2015;172(3):807-810.
Alinia H, Feldman SR. Oral tofacitinib for psoriasis: what happens with interrupted treatment? [commentary]. Br J Dermatol. 2015;172(5):1194-1195.
Farhangian ME, Feldman SR. Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate. Am J Clin Dermatol. 2015;16(4):285-294.
Farhangian ME, Feldman SR. Moving away from fee-for-service: implications for medication adherence. South Med J. 2015;108(5):298-299.
Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol. 2015;151(10):1081-1086.
Ali ST, Alinia H, Feldman SR. The treatment of rosacea with topical ivermectin. Drugs Today (Barc). 2015;51(4):243-250.
Armstrong AW, Feldman SR, Korman NJ, Meng X, Guana A, Nyirady J, Herrera V, Zhao Y. Efficacy of secukinumab in patients with plaque psoriasis: area under the curve of treatment reponse rates [abstract]. Value Health. 2015;18(3):A179.
Aslam I, Feldman SR. Practical strategies to improve patient adherence to treatment regimens. South Med J. 2015;108(6):325-331.
Feldman SR. Inflammatory diseases: integrating biosimilars into clinical practice. Semin Arthritis Rheum. 2015;44(6 Suppl):S16-S21.
Feldman SR, Herrera V, Zhao Y, Shi L. Timing of first-time use of biologics and healthcare costs and utilization in psoriasis [abstract]. Value Health. 2015;18(3):A296.
Feldman SR, Princic N, Zhao Y, Barghout V, Willson T, Song X, Guana A, Herrera V. Mortality risk in patients with psoriasis [abstract]. Value Health. 2015;18(3):A294.
Feldman SR, Zhao Y, Shi L, Tran MH, Lu J. Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis. Arthritis Care Res (Hoboken). 2015;67(5):708-717.
Taheri A, Davis SA, Huang KE, Feldman SR. Onychomycosis treatment in the United States. Cutis. 2015;95(5):E15-E21.
Aslam I, Davis SA, Feldman SR, Martin WE. A review of patient lifting interventions to reduce health care worker injuries. Workplace Health Saf. 2015;63(6):267-275.
Bass AM, Farhangian ME, Feldman SR. Internet-based adherence interventions for treatment of chronic disorders in adolescents. Adolesc Health Med Ther. 2015;6():91-99.
Culp L, Moradi Tuchayi S, Alinia H, Feldman SR. Tolerability of topical retinoids: are there clinically meaningful differences among topical retinoids?. J Cutan Med Surg. 2015;():.
Papp KA, Menter MA, Abe M, Elewski B, Feldman SR, Gottlieb AB, Langley R, Luger T, Thaci D, Buonanno M, Gupta P, Proulx J, Lan S, Wolk R. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two, randomised, placebo-controlled, Phase 3 trials. Br J Dermatol. 2015;():.
Snyder A, West SE, Miles CM, Feldman SR. Obtaining an adequate specimen for the diagnosis of pigmented lesions. J Am Board Fam Med. 2015;28(4):523-525.
Bass AM, Anderson KL, Feldman SR. Interventions to increase treatment adherence in pediatric atopic dermatitis: a systematic review. J Clin Med. 2015;4(2):231-242.
Eichenfield LF, Boguniewicz M, Simpson EL, Russell JJ, Block JK, Feldman SR, Clark AR, Tofte S, Dunn JD, Paller AS. Translating atopic dermatitis management guidelines into practice for primary care providers. Pediatrics. 2015;136(3):554-565.
Farhangian ME, Snyder A, Huang KE, Doerfler L, Huang WW, Feldman SR. Cutaneous cryosurgery in the United States. J Dermatolog Treat. 2015;():.
Ahn CS, Dothard EH, Garner ML, Feldman SR, Huang WW. To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2015;73(3):420-428.e1.
Anderson KL, Huang KE, Huang WW, Feldman SR. Training for prescribing in-office and home phototherapy. Photodermatol Photoimmunol Photomed. 2015;31(6):325-332.
Farhangian ME, Barnes LE, Huang KE, Feldman SR. How often do pharmacology textbooks address medication adherence? [editorial]. J Dermatolog Treat. 2015;26(3):199-201.
Hill D, Feldman SR. How to manage the mother of all treatment refusal [editorial]. J Dermatolog Treat. 2015;26(5):395.
Ahn C, Dothard E, Garner M, Feldman S, Huang W. Screening and monitoring tests during the use of biologic agents to treat psoriasis and psoriatic arthritis: an evidence-based assessment of current recommendations [abstract]. J Am Acad Dermatol. 2015;72(5 Suppl 1):AB248.
Anderson K, Dothard E, Huang K, Feldman S. Primary nonadherence to acne treatment [abstract]. J Am Acad Dermatol. 2015;72(5 Suppl 1):AB10.
Anderson K, Feldman S. Treatment changes in patients with moderate to severe psoriasis [abstract]. J Am Acad Dermatol. 2015;72(5 Suppl 1):AB256.
Feldman S, Bushnell D, Viswanathan H, Martin M, Wade S, Scanlon M, Yang WJ, Pinto L, Kircik L, Klekotka P. Differences in patient reported psoriasis symptom severity between patients rated as 'clear' versus 'almost clear' based on Physician Global Assessment [abstract]. J Am Acad Dermatol. 2015;72(5 Suppl 1):AB230.
Feldman S, Bushnell D, Viswanathan HN, Martin M, Wade SW, Scanlon M, Yang WJ, Pinto L, Kircik L, Klekotka PA. Differences in patient reported psoriasis symptom severity between patients rated as 'clear' versus 'almost clear' based on Physician Global Assessment [abstract]. J Invest Dermatol. 2015;135(Suppl 3):S33.
Feldman S, Kimball AB, Warren RB, Frazier D, Proulx J, Marren A. Pregnancy outcomes in the tofacitinib psoriasis safety database up to April 2014 [abstract]. J Invest Dermatol. 2015;135(Suppl 3):S9.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.